Short answer
Astrana Health, Inc. (ASTH) filed its Q1 2026 10-Q quarterly report on May 8, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $965M with net income of $14M.
Q1 2026 key financials · XBRL
- Revenue
- $965M
- Net income
- $14M
- Operating margin
- 3.0%
- EPS (diluted)
- $0.29
Source: XBRL data from the Astrana Health, Inc. (ASTH) Q1 2026 10-Q on SEC EDGAR. USD.
Astrana Health, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $965.1M, up 56% YoY from $620.4M, including $300.2M from Prospect acquisition
- Operating margin 3.0% vs 3.3% YoY; net income $13.1M vs $6.2M
- Adjusted EBITDA $66.3M, up from $36.4M; margin 6.9% vs 5.9% YoY
- Fee-for-service revenue strongest growth, $37.8M, up 154%; risk pool settlements weakest, $12.5M, down 14%
- Borrowings increased to $1,040.3M from $412.0M, financing Prospect acquisition; 2027 CMS rates expected to benefit Astrana
Risk Factors
- No material changes in risk factors from the December 31, 2025 Form 10-K
- Carried-forward healthcare-industry and company-specific risks remain applicable to operations
- Unknown or currently immaterial risks could materially adversely affect business, cash flows, or results
- Historical performance may not reliably indicate future results
- Stock price remains exposed to adverse effects from disclosed risk factors
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Astrana Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.